TITLE

THE NEW (6TH EDITION) TNM CLASSIFICATION OF COLORECTAL CANCER--A STAGE TOO FAR

AUTHOR(S)
Howarth, S. M.; Morgan, J. M.; Williams, G. T.
PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA21
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article focuses on the new 6th edition TNM classification of colorectal cancer. The new 6th edition of the TNM staging classification of colorectal cancer changes the histological criteria for interpreting extramural tumour nodules. Changes to TNM staging in the 6th edition have replaced an objective criterion with one that is subjective and not reproducible by pathologists. Application of the new TNM classification "upstages" up to 11% of 13 colorectal cancers. This has implications for patient treatment, clinical trials and cancer intelligence.
ACCESSION #
13218897

 

Related Articles

  • CLINICAL X-RAY STAFF CONFERENCES ON THE COLON IV. MULTIPLE NEOPLASMS OF THE COLON. Ferguson, Lynn A.; Ferguson, James A.; Van Zwalenburg, Ben R.; Ducey, Edward F. // American Journal of Gastroenterology;Jun1954, Vol. 21 Issue 6, p495 

    Focuses on a research on several cases of colon diseases before the Eighteenth Annual Convention of the National Gastroenterological Association in Los Angeles, California from October 12 to 14, 1953. Redness of the mucosa of the distal ampulla; Soft polypoid tumor; Multiple primary neoplasms.

  • The rare epidemiologic coincidence of diverticular disease and advanced colonic neoplasia. Krones, C. J.; Klinge, U.; Butz, N.; Junge, K.; Stumpf, M.; Rosch, R.; Hermanns, B.; Heussen, N.; Schumpelick, V. // International Journal of Colorectal Disease;Jan2006, Vol. 21 Issue 1, p18 

    The article presents a study which evaluated the epidemiologic coincidence of diverticulitis disease and advanced colonic neoplasia. All study patients were recruited from the Surgical Department of the Rhenish-Westfalian Technical University Aachem. Patients were subdivided into the cancer...

  • Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression. Friederichs, Jan; Rosenberg, Robert; Mages, Joerg; Janssen, Klaus-Peter; Maeckl, Christian; Nekarda, Hjalmar; Holzmann, Bernhard; Siewert, Joerg-Ruediger // International Journal of Colorectal Disease;Sep2005, Vol. 20 Issue 5, p391 

    Presents information on a study which described the gene expression profiles of different clinical stages of colorectal carcinoma. Medical history of the patients; Materials and methods; Number of genes that were regulated in primary tumors of colorectal carcinoma; Results and discussion;...

  • Colorectal Cancer.  // Diseases & Disorders: A Nursing Therapeutics Manual, 2nd edition;2002, p260 

    Provides information on colorectal cancer. Causes; Assessment and diagnosis; Treatment.

  • Leiomyosarcoma of the Colon: Unresolved Issues of a Rare but Highly Aggressive Malignancy. Resch, Thomas; Oberhuber, Rupert; Zitt, Mathias; Laimer, Elisabeth; Gehwolf, Philipp; Pratschke, Johann; Klaus, Alexander // American Surgeon;Apr2011, Vol. 77 Issue 4, pE62 

    The article discusses leiomyosarcoma (LMS) of the colon, a highly aggressive malignancy and rare disease with poor prognosis. The clinical courses of LMS of the colon in two patients, a 70-year-old woman and a 56-year-old man, are discussed. A computed tomography image shows an obstructing tumor...

  • Rectosigmoid adenocarcinoma revealed by metastatic anal fistula. The visible part of the iceberg: a report of two cases with literature review. Benjelloun, El Bachir; Aitalalim, Said; Chbani, Leila; Mellouki, Ihsan; Mazaz, Khalid; Aittaleb, Kahlid // World Journal of Surgical Oncology;2012, Vol. 10 Issue 1, p209 

    Colonic adenocarcinoma revealed by metastatic anorectal fistula is rare, with few cases in the literature. Such lesions can be taken for the more common manifestation of a benign perianal abscess or fistula. Once diagnosed, the management of such conditions remains controversial. We herein...

  • Cancer colorectal: stratégies thérapeutiques en situation métastatique. Senellart, H.; Hiret, S.; Bennouna, J. // Oncologie;Oct2010, Vol. 12 Issue 10, p593 

    During the last 20 years, management for metastatic colorectal cancer has been strongly modified. Advances in the systemic treatment, increased use of metastatic resections, and multidisciplinary approach in a systematic way have improved the overall survival from 14 months in 1990 to 30 months...

  • KRAS status predicted cetuximab benefit.  // Hem/Onc Today;11/10/2008, Vol. 9 Issue 20, p16 

    The article discusses a study on the efficacy of cetuximab monotherapy in patients with advanced colorectal cancer bearing mutated KRAS tumors. According to Christos Karapetis of Flinders University, they see no difference when they looked at patients with cancers with mutations in KRAS and...

  • An Open-Labeled, Randomized Study Comparing Systemic Interferon-α-2A and Prednisolone Enemas in the Treatment of Left-Sided Ulcerative Colitis. Madsen, S. M.; Schlichting, P.; Davidsen, B.; Nielsen, O. H.; Federspiel, B.; Riis, P.; Munkholm, P. // American Journal of Gastroenterology;Jun2001, Vol. 96 Issue 6, p1807 

    OBJECTIVE: The aim of this study was to compare the treatment efficacies of subcutaneous interferon-α-2A (IFN-α- 2A) injections versus prednisolone enemas in active left-sided ulcerative colitis in an open-labeled, randomized study. METHODS: Sixteen ulcerative colitis patients...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics